January 18, 2022

European Medicines Agency validates use of Johnson & Johnson vaccine for booster doses

This is the third vaccine, after those from Pfizer / BioNTech and Moderna, that can be used in the EU for a booster in adults.

Article written by

Posted

Update

Reading time : 1 min.

One more vaccine authorized for booster doses in the European Union. The European Medicines Agency (EMA) said on Wednesday (December 15) that the Janssen vaccine, from Johnson & Johnson, could be used for booster doses at least two months after the first dose in people 18 years and older . “The recommendation follows data showing that a booster dose of the Janssen Covid-19 vaccine given at least two months after the first dose in adults resulted in an increase in antibodies to Sars-CoV-2”, the EMA said in a statement (link in English).

>>> Covid-19: follow all the news on the epidemic live

This is the third vaccine – after those from Pfizer / BioNTech and Moderna – to be able to be used in the EU for a booster in adults.

The EMA Committee for Medicinal Products for Human Use (CHMP) has also concluded that a booster dose with the Johnson & Johnson vaccine can be given after two doses of any of the messenger RNA vaccines authorized in the EU. , Pfizer or Moderna.

Note that the administration of a booster dose of a vaccine against Covid-19 different from that received during the first injections in some cases elicits a stronger immune response, according to European health authorities.